{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pelizaeus-merzbacher-disease-in-female-carriers","columns":[{"gene":"","key":"population-4eac8e1501392690087e","label":"Pelizaeus-Merzbacher disease in female carriers","mondoId":"MONDO:0017224","onsetQualifier":null,"originColumnKey":"MONDO:0017224/ORPHA:280229","originalViews":[{"key":"MONDO:0017224/ORPHA:280229","label":"Pelizaeus-Merzbacher disease in female carriers","scopeLabel":"ORPHA:280229","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0ee86e04ee935d0e7a4cec9b892a51631bf0047e88b293e84688353ed35581c7","15e25483f53535862ecf3bf9a3237868c3110c7b94db5ac37e8fcedeac9d6604","204643253d03dc6c12f58563f71270e9e7c3b0b3a0f570bfab1572fbdc1f0ecc","363e8d20b4823c7038470774c8a44207b274453cb2f87a778f87043846723898","378f0a3772c2b047425d1389210263544670d60a74ae8bfb93d6431b95602243","3b6556f2740b999aa94e2cfb536babce267fb47f8cbe5095dac523aa6131a906","3be7a08670d5ed998b03d110e4b367c2ad6c376d0c1bd3ca501f539104eacc6f","3d40c69cc2ce89637bd5fe340bb2cdddbd9abf7783fa5dde7d3a1fcb3720c072","463ae57a44c4783034686ae4e747eb08c84529bc8bfd0cad7f2573244d91e727","469409018b7cd27e4e38bae82f8bbd4f672dbe9178a9a1e2180308ed08aa794f","6f61344ea9db6fa1232cdce05f8060489e5f4f1a407c8922fa45d29eaff7e152","7e53058cade092d471a0dc83299dcdff3a38e052a5645f6194cf72df6d40702c","8bbf98451932e69e7dfe067f83397dae268fc0b54634ce5127f110de1c2f891d","8dcd229c84b68d399dae13cff51a9fdb0f399b3e88f5e5dea2d146fcb64c5b1c","abd9b70155455a5c361139f77f2b283d6f98284363c60535cb07ca22ab4642db","b3043230c258f7e3725ffa1142a76ec1dfc1c127b8d951ac6fdbd1d09150d38d","b9b41daa48472955984f812c75c7e02ce960d19180a447b5147d94cee5273135","c9583cf88116938d4e0cd927c01fb1845f67da35667d4c2726ac0f7a105bb99b","d2c586252004f34d5ec6752b766842955a9230364eb5a24b56228b30f6f06e2c","d5638491fd01c6ba7f237c4b7fd533eee3474b3ceafcfdcc27ec61d1c9a4411d","d6dd5eb709091fb3143f4f5b230e99a252f12f01d83b9a34c2ce3a3bd61d57c2","dd491e4922a2a7487878ac8b48879da347139b2060ff536bbbafdeb4109d2ed9","e0c321a23ef429eeafc688ccc3ec461a69a376d64f3b56d8ca08cad71ca5cff9","e7c0f34bf79d72f71f28e67714493df6c8eb49a87e0289cd68f3f1a6dbde9830","e81ad70f5c99f43915267407a2ce51bedb4a6ddfcad190087b645206f84bcbe0","e8de7034a02766e7d8219d2e83cdd66d1360c68b8279f59e64e8d315eff8e2d5","ea3499891bc4cccbd9feeadeaa6cdf73815c98f1e2cc3734d33696638de7ff81","eef6853f59400b62dd4d0d90b66d999dcd85fd5130ba6a6abc6279ec3613eee4"],"recordQualifiers":{},"scopeLabel":"ORPHA:280229","sourceIds":["ORPHA:280229"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4eac8e1501392690087e"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001273","HP:0002167","HP:0010936","HP:0030784","HP:0003487","HP:0003429","HP:0032044"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"orphanet":28}},"features":[{"hpoId":"HP:0001273","label":"Abnormal corpus callosum morphology","primary":true},{"hpoId":"HP:0002167","label":"Abnormal speech pattern","primary":true},{"hpoId":"HP:0010936","label":"Abnormality of the lower urinary tract","primary":true},{"hpoId":"HP:0030784","label":"Anomic aphasia","primary":true},{"hpoId":"HP:0003487","label":"Babinski sign","primary":true},{"hpoId":"HP:0003429","label":"CNS hypomyelination","primary":true},{"hpoId":"HP:0032044","label":"Decreased vigilance","primary":true},{"hpoId":"HP:0000490","label":"Deeply set eye","primary":false},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0002197","label":"Generalized-onset seizure","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0032588","label":"Hand apraxia","primary":false},{"hpoId":"HP:0000666","label":"Horizontal nystagmus","primary":false},{"hpoId":"HP:0030890","label":"Hyperintensity of cerebral white matter on MRI","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0000316","label":"Hypertelorism","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0002061","label":"Lower limb spasticity","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0011800","label":"Midface retrusion","primary":false},{"hpoId":"HP:0011342","label":"Mild global developmental delay","primary":false},{"hpoId":"HP:0011343","label":"Moderate global developmental delay","primary":false},{"hpoId":"HP:0000011","label":"Neurogenic bladder","primary":false},{"hpoId":"HP:0007413","label":"Nevus flammeus of the forehead","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0002313","label":"Spastic paraparesis","primary":false}],"ledeHtml":"Pelizaeus-Merzbacher disease (PMD) in female carriers is the presentation of PMD in some women carrying mutations in the PLP1 gene (Xq22).","mondoId":"MONDO:0017224","node":{"canonicalSlug":"pelizaeus-merzbacher-disease-in-female-carriers","comparisons":[{"documentSha256":"c25393f3845210f6a1e5f8f8ee849a3038ad6f06279f89ec3c0e7c9c4b511a07","key":"legacy-pelizaeus-merzbacher-disease","kind":"legacy","label":"Pelizaeus-Merzbacher spectrum disorder","memberIds":["MONDO:0010714","MONDO:0017221","MONDO:0017222","MONDO:0017223","MONDO:0017224","MONDO:0017225"],"mondoId":"MONDO:0010714","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pelizaeus-merzbacher-disease.c25393f3845210f6a1e5f8f8ee849a3038ad6f06279f89ec3c0e7c9c4b511a07.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Pelizaeus-Merzbacher disease in female carriers","paragraphs":["Pelizaeus-Merzbacher disease (PMD) in female carriers is the presentation of PMD in some women carrying mutations in the PLP1 gene (Xq22)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:280229","url":"https://monarchinitiative.org/MONDO:0017224"},"ownColumnKeys":["population-4eac8e1501392690087e"],"publication":"published","relationships":[{"kind":"parent","label":"Pelizaeus-Merzbacher spectrum disorder","mondoId":"MONDO:0010714","slug":"pelizaeus-merzbacher-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/21075"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"0ee86e04ee935d0e7a4cec9b892a51631bf0047e88b293e84688353ed35581c7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"15e25483f53535862ecf3bf9a3237868c3110c7b94db5ac37e8fcedeac9d6604","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"204643253d03dc6c12f58563f71270e9e7c3b0b3a0f570bfab1572fbdc1f0ecc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011343","is_excluded":false,"label":"Moderate global developmental delay","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"363e8d20b4823c7038470774c8a44207b274453cb2f87a778f87043846723898","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"378f0a3772c2b047425d1389210263544670d60a74ae8bfb93d6431b95602243","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b6556f2740b999aa94e2cfb536babce267fb47f8cbe5095dac523aa6131a906","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030784","is_excluded":false,"label":"Anomic aphasia","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3be7a08670d5ed998b03d110e4b367c2ad6c376d0c1bd3ca501f539104eacc6f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003487","is_excluded":false,"label":"Babinski sign","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d40c69cc2ce89637bd5fe340bb2cdddbd9abf7783fa5dde7d3a1fcb3720c072","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"463ae57a44c4783034686ae4e747eb08c84529bc8bfd0cad7f2573244d91e727","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"469409018b7cd27e4e38bae82f8bbd4f672dbe9178a9a1e2180308ed08aa794f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0032044","is_excluded":false,"label":"Decreased vigilance","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f61344ea9db6fa1232cdce05f8060489e5f4f1a407c8922fa45d29eaff7e152","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002197","is_excluded":false,"label":"Generalized-onset seizure","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7e53058cade092d471a0dc83299dcdff3a38e052a5645f6194cf72df6d40702c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001273","is_excluded":false,"label":"Abnormal corpus callosum morphology","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8bbf98451932e69e7dfe067f83397dae268fc0b54634ce5127f110de1c2f891d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000666","is_excluded":false,"label":"Horizontal nystagmus","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8dcd229c84b68d399dae13cff51a9fdb0f399b3e88f5e5dea2d146fcb64c5b1c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002061","is_excluded":false,"label":"Lower limb spasticity","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"abd9b70155455a5c361139f77f2b283d6f98284363c60535cb07ca22ab4642db","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010936","is_excluded":false,"label":"Abnormality of the lower urinary tract","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3043230c258f7e3725ffa1142a76ec1dfc1c127b8d951ac6fdbd1d09150d38d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b9b41daa48472955984f812c75c7e02ce960d19180a447b5147d94cee5273135","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030890","is_excluded":false,"label":"Hyperintensity of cerebral white matter on MRI","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9583cf88116938d4e0cd927c01fb1845f67da35667d4c2726ac0f7a105bb99b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000490","is_excluded":false,"label":"Deeply set eye","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d2c586252004f34d5ec6752b766842955a9230364eb5a24b56228b30f6f06e2c","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007413","is_excluded":false,"label":"Nevus flammeus of the forehead","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5638491fd01c6ba7f237c4b7fd533eee3474b3ceafcfdcc27ec61d1c9a4411d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0032588","is_excluded":false,"label":"Hand apraxia","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d6dd5eb709091fb3143f4f5b230e99a252f12f01d83b9a34c2ce3a3bd61d57c2","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000316","is_excluded":false,"label":"Hypertelorism","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd491e4922a2a7487878ac8b48879da347139b2060ff536bbbafdeb4109d2ed9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0c321a23ef429eeafc688ccc3ec461a69a376d64f3b56d8ca08cad71ca5cff9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003429","is_excluded":false,"label":"CNS hypomyelination","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e7c0f34bf79d72f71f28e67714493df6c8eb49a87e0289cd68f3f1a6dbde9830","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002167","is_excluded":false,"label":"Abnormal speech pattern","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e81ad70f5c99f43915267407a2ce51bedb4a6ddfcad190087b645206f84bcbe0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011342","is_excluded":false,"label":"Mild global developmental delay","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e8de7034a02766e7d8219d2e83cdd66d1360c68b8279f59e64e8d315eff8e2d5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002313","is_excluded":false,"label":"Spastic paraparesis","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ea3499891bc4cccbd9feeadeaa6cdf73815c98f1e2cc3734d33696638de7ff81","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011800","is_excluded":false,"label":"Midface retrusion","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eef6853f59400b62dd4d0d90b66d999dcd85fd5130ba6a6abc6279ec3613eee4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:280229","disease_name":"Pelizaeus-Merzbacher disease in female carriers","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000011","is_excluded":false,"label":"Neurogenic bladder","onset_id":null,"reference":"ORPHA:280229","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017224\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:280229</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Pelizaeus-Merzbacher disease (PMD) in female carriers is the presentation of PMD in some women carrying mutations in the PLP1 gene (Xq22).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017224\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pelizaeus-merzbacher-disease-in-female-carriers","sourceDocuments":[{"name":"MONDO: Pelizaeus-Merzbacher disease in female carriers","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017224"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"Pelizaeus-Merzbacher disease in female carriers"},"schemaVersion":1}
